Chia Tai Enterprises International (HKG:3839) recorded an attributable profit of $5.6 million in the first quarter, down from $7.7 million a year prior.
Revenue slipped to $99 million from $165 million in the year-ago period, according to a Tuesday Hong Kong bourse filing from the biotech and investment business.